Cytek director exercises 6,107 RSUs into shares
Cytek Biosciences, Inc. director Richard Chin reported a routine equity compensation event.
Rhea-AI Filing Summary
Cytek Biosciences, Inc. director Richard Chin reported a routine equity compensation event. On May 18, 2026, he exercised 6,107 Restricted Stock Units, receiving the same number of shares of common stock at a stated price of $0.00 per share.
Following the transaction, Chin directly holds 22,392 shares of Cytek common stock and 50,897 Restricted Stock Units. The RSU Award represents the right to receive one share of common stock per unit and is scheduled to vest in multiple tranches between August 18, 2025 and August 18, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
6,107 shares exercised/converted
Exercise
2 txns
Insider
Chin Richard
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 6,107 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,107 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 50,897 contracts (Direct);
Common Stock — 22,392 shares (Direct)
Footnotes (2)
- F1. Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- F2. 2/36 of the total shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2025 and each November 18 thereafter; 3/36 of the total shares underlying the RSU Award shall vest on March 10, 2026 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2026 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2026 and each August 18 thereafter, until fully vested.
Key Figures
RSUs exercised: 6,107 units
Shares received: 6,107 shares
Common shares held: 22,392 shares
+1 more
4 metrics
RSUs exercised
6,107 units
Restricted Stock Units converted to common stock on May 18, 2026
Shares received
6,107 shares
Common stock issued from RSU exercise at $0.00 per share
Common shares held
22,392 shares
Direct holdings after the reported transaction
RSUs remaining
50,897 units
Restricted Stock Units directly held after the transaction
Key Terms
Restricted Stock Units, RSU Award, vesting, derivative exercise/conversion, +1 more
5 terms
Restricted Stock Units financial
"The RSU Award represents a contingent right to receive one share of the Issuer's common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU Award financial
"Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share"
vesting financial
"shares subject to the RSU Award shall vest on August 18, 2025; 3/36 of the total shares subject"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
Common Stock financial
"underlying_security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cytek Biosciences (CTKB) report for Richard Chin?
Cytek Biosciences director Richard Chin exercised 6,107 Restricted Stock Units, receiving 6,107 shares of common stock at a stated price of $0.00 per share. This is a derivative exercise, not an open-market stock purchase or sale.
What are Restricted Stock Units (RSUs) in the Cytek Biosciences (CTKB) Form 4?
In this filing, each Restricted Stock Unit represents a contingent right to receive one share of Cytek common stock. These RSUs vest over time according to a defined schedule and convert into common shares upon vesting and settlement.
What is the vesting schedule for Richard Chin’s RSU Award at Cytek Biosciences (CTKB)?
The RSU Award vests in tranches: portions vest on August 18, 2025, November 18, 2025 and each November 18 thereafter, March 10, 2026 and each March 10 thereafter, May 18, 2026 and each May 18 thereafter, and August 18, 2026 and each August 18 thereafter.
Was Richard Chin’s Cytek Biosciences (CTKB) transaction a stock sale?
No. The Form 4 shows a derivative exercise coded “M,” where 6,107 Restricted Stock Units were converted into 6,107 shares of common stock. There were no open-market sales or purchases reported in this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
